Transcranial magnetic stimulation (TMS): Market Size (Value)
Unfortunately, following extensive searches online through publicly available resources, we could not determine the U.S. market size for transcranial magnetic stimulation (TMS) including information on how the market has expanded over the past three years. However, a report by Market Watch hidden behind a paywall likely contains information on the topic. Below is a detailed explanation of the search processes used to uncover the relevant findings presented and ascertain why the data is not publicly available.
We started by searching for publicly available information in various news articles, news reports, press releases, business news and reports published by different credible websites like Forbes, CNN, NC, and BBC, but we managed to find only news, articles, press releases about the general overview of transcranial magnetic stimulation (TMS). No information specific to the U.S. market size for transcranial magnetic stimulation (TMS), and how has that market grown over the past three years was found.
Second, we tried searching for market and industry reports on transcranial magnetic stimulation, but found that most of them require a full purchase or paid subscription to access the contents. Moreover, the reports covered the North American market, and none specifically mentioned the U.S. market. We came across a report by Market Watch, which based on its heading, features information about the transcranial magnetic stimulators (TMS) market in the U.S., but is hidden behind a paywall.
Third, we attempted to look for information regarding the top companies in the transcranial magnetic stimulation industry such as Magstim, Neuronetics and Deymed Diagnostic in the U.S. hoping to retrieve their revenues, which would assist in triangulating the figure; unluckily, we could not uncover any details regarding their finances in the respective companies’ news and media sections. The only prevalent data on the topic was on the companies’ products and services.
Lastly, we extended the research time frame to include sources over 24 months old hoping to find information about forecasts into the future. Likewise, no relevant data was uncovered. Most reports concentrated on providing an overview of the market, key trends, and how the market is shared globally.
We suspect that the information is lacking because no studies, research, articles, and news reports have made the data public, especially for the U.S. market size of transcranial magnetic stimulation (TMS), and how it has grown over the past three years.
TRANSCRANIAL MAGNETIC STIMULATION
According to Market Watch report, the estimated global transcranial magnetic stimulators market in 2019 in $71 million and is expected to reach approximately $130 million in 2024. In 2017, North America emerged as the largest consumer of transcranial magnetic stimulation and held 32.3% market share.
Transcranial magnetic stimulation (TMS) is considered one of the best-tested neurostimulation technique to treat mood disorders. The top vendors in this sector include Axilum Robotics, Mastigm, Nexstim PLC., Neuronetics, Inc., Brainsway Ltd., and TMS Neuro Solutions.
PAywalled REPORTS LIKELY CONTAINING THE U.S. DATA
Market Watch contains a report likely to feature information regarding the U.S. transcranial magnetic stimulators (TMS) market size but is behind a paywall. Arvada Daily also features a paywalled report with information regarding the top manufacturers of transcranial magnetic stimulators (TMS) in the U.S. The report further provides the scope of transcranial magnetic stimulators (TMS) market by region, which also includes the U.S. market.